Our Therapeutic Laser Technology division is focused on the development and commercialization of laser-based non-invasive therapeutic devices to eliminate pain, reduce inflammation, and accelerate tissue healing.
This division currently produces more than 25 models of cool laser therapy ("CLT") devices that are utilized by practitioners in healthcare clinics around the world.
Theralase® patented superpulsed laser devices are clinically indicated and cleared by global regulatory bodies for the treatment of chronic knee pain, and in off-label use, the elimination of pain, reduction of inflammation, and dramatic acceleration of tissue healing for numerous nerve, muscle, and joint conditions.
Theralase® is the most clinically and scientifically supported therapeutic medical laser on the market, and is committed to providing cutting-edge pre-clinical and clinical research. Our customers receive the most advanced therapeutic laser technology on the market, supported by superior customer service, interactive training, and the most up-to-date clinical protocols to ensure the success of their practice.
Our anti-cancer technology has now successfully completed a Phase 1b Clinical Study for Non-Muscle Invasive Bladder Cancer ("NMIBC"). We are currently designing a Phase II Non-Muscle Invasive Bladder Cancer Clinical Study.
How Our Low-Level Lasers Work
More specialized information for..